Angel News

Angel News

Back to Homepage

19th October 2017

Maven Capital Partners has exited its investment in Crawford Scientific, a leading supplier of chromatography products and analytical services to the laboratory research and testing sectors, following its sale to Limerston Capital Partners I, LP. The sale realised a return for Maven clients of 4.7x the initial investment in just over three years, with an IRR of 70%. 

...

Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:

Name:

Email:

Comment:

Enter the characters in the image shown:



Back to Homepage